Not applicableWithdrawnNCT05738226What this trial is testingEpiCare@Home Validation Study for Focal Onset SeizuresWho this might be right forEpilepsySeizuresSeizures, Focal+1 more Byteflies
Large-scale testing (Phase 3)Study completedNCT01392768What this trial is testingEfficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary GeneralizationWho this might be right forEpilepsyPartial Seizures Ache Laboratorios Farmaceuticos S.A. 126
Large-scale testing (Phase 3)Study completedNCT03250377What this trial is testingTest the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary GeneralizationWho this might be right forPartial Seizures With or Without Secondary GeneralizationEpilepsy UCB Biopharma SRL 207
Post-approval studies (Phase 4)Ended earlyNCT01266291What this trial is testingSabril for Complex Partial Seizures in Adult Tolerability Study (TS) PatientsWho this might be right forComplex Partial Seizures University of Pennsylvania 1
Post-approval studies (Phase 4)Ended earlyNCT05605756What this trial is testingBOTOX Effects on Seizure Severity and SusceptibilityWho this might be right forDrug-resistant Focal Seizure Beth Israel Deaconess Medical Center 3
Not applicableStudy completedNCT03082222What this trial is testingZEDEBAC: Zebinix Effects in Dependency of Baseline ConditionsWho this might be right forFocal Epilepsy Eisai GmbH 246
Large-scale testing (Phase 3)Study completedNCT00957372What this trial is testingEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial EpilepsyWho this might be right forPartial Epilepsy Bial - Portela C S.A. 253
Testing effectiveness (Phase 2)Study completedNCT01159431What this trial is testingExternal Trigeminal Nerve Stimulation for EpilepsyWho this might be right forEpilepsySeizure Disorders Olive View-UCLA Education & Research Institute 50
Testing effectiveness (Phase 2)Study completedNCT00938431What this trial is testingA Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial SeizuresWho this might be right forEpilepsy UCB Pharma 47
Post-approval studies (Phase 4)Study completedNCT01630057What this trial is testingEvaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic DrugWho this might be right forPartial Seizures Eisai Inc. 200
Large-scale testing (Phase 3)Study completedNCT03340064What this trial is testingLevetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of AgeWho this might be right forPartial Seizures UCB Japan Co. Ltd. 38
Early research (Phase 1)Active Not RecruitingNCT06899230What this trial is testingSafety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007Who this might be right forDrug Resistant EpilepsyFocal Seizure iQure Australia Pty Ltd 72
Testing effectiveness (Phase 2)Study completedNCT03283371What this trial is testingPhase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal EpilepsyWho this might be right forEpilepsy, Focal Seizures, Partial Seizures Biogen 67
Large-scale testing (Phase 3)Study completedNCT01618695What this trial is testingA Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset SeizuresWho this might be right forPartial-onset Seizures Eisai Co., Ltd. 940
Not applicableLooking for participantsNCT06466681What this trial is testingChanges in Attentional Control After a Focal Seizure.Who this might be right forTemporal Lobe EpilepsyFrontal Lobe EpilepsyOthers Subtypes University Hospital, Lille 100
Large-scale testing (Phase 3)Study completedNCT01262677What this trial is testingOnce-A-Day Pregabalin For Partial SeizuresWho this might be right forPartial SeizuresEpilepsies, Partial Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 325
Post-approval studies (Phase 4)Study completedNCT00288639What this trial is testingLyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).Who this might be right forEpilepsy Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 98
Large-scale testing (Phase 3)WithdrawnNCT03108729What this trial is testingA Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the DrugWho this might be right forEpilepsy Sumitomo Pharma America, Inc.
Large-scale testing (Phase 3)Study completedNCT00236743What this trial is testingThe Effectiveness and Safety of Topiramate in the Treatment of Children With EpilepsyWho this might be right forEpilepsyEpilepsies, PartialSeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 90
Large-scale testing (Phase 3)Study completedNCT00355082What this trial is testingConversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial EpilepsyWho this might be right forEpilepsy, Partial GlaxoSmithKline 226